Josh Hardy Going Home After Getting Chimerix, Inc. (CMRX)'s Anti-Viral Drug Brincidofovir
7/18/2014 6:58:24 AM
Social media campaigns for “compassionate use” access to drugs still in clinical trials got a big boost yesterday. The mother of Josh Hardy, a now-8-year-old boy suffering with cancer for nearly all of his life, announced on Facebook and the family’s CaringBridge.com website that the boy was going home to Virginia from St. Jude Children’s Hospital, months after receiving an experimental drug for a life-threatening adenovirus infection.
Hey, check out all the research scientist jobs. Post your resume today!
comments powered by